PLRX — Pliant Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Pliant Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	103	277	201	331	494
Net Total Accounts Receivable
Net Total Receivables	7.38	9.36	2.08	2.07	3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	112	291	209	340	506
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.08	4.32	10.9	9.91	4.78
Other Long Term Assets
Total Assets	119	296	221	351	512
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	8.17	11.6	16.8	23.9	28.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.08	12.5	22.2	37.3	38.6
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	110	283	199	313	474
Total Liabilities & Shareholders' Equity	119	296	221	351	512
Total Common Shares Outstanding